Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report
Cutaneous reactions have been commonly associated with the Moderna messenger RNA (mRNA) COVID-19 vaccine. Among the reported cutaneous side effects, there have not been any associations reported yet regarding keratoacanthoma development after COVID-19 mRNA vaccination. We report a novel c...
Main Authors: | Fahad Ahmed, Nashwah Memon, Adel Haque |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-12-01
|
Series: | JMIR Dermatology |
Online Access: | https://derma.jmir.org/2022/4/e41739 |
Similar Items
-
Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
by: Alex Drohan, MD, et al.
Published: (2021-10-01) -
Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
by: Antonio Cuadrado, et al.
Published: (2022-07-01) -
Pityriasis rubra pilaris potentially triggered by messenger RNA–1273 COVID vaccine
by: Etsubdenk M. Ajebo, MD, et al.
Published: (2022-05-01) -
New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
by: Joshua Kaminetsky, et al.
Published: (2021-09-01) -
Eruptive keratoacanthomas secondary to topical 5-fluorouracil application
by: Estefanía Cruzval-O'Reilly, MD, et al.
Published: (2021-10-01)